Rhumbline Advisers Simulations Plus, Inc. Transaction History

Rhumbline Advisers

  • $113 Billion
  • Q2 2025

A detailed history of Rhumbline Advisers transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 74,325 shares of SLP stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,325
Previous 66,222 12.24%
Holding current value
$1.23 Million
Previous $1.62 Million 20.15%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$16.86 - $35.88 $136,616 - $290,735
8,103 Added 12.24%
74,325 $1.3 Million
Q1 2025

Apr 08, 2025
BUY
$24.0 - $37.01 $32,016 - $49,371
1,334 Added 2.06%
66,222 $1.61 Million
Q4 2024

May 29, 2025
SELL
$27.22 - $34.28 $36,311 - $45,729
-1,334 Reduced 2.01%
64,888 $1.81 Million
Q4 2024

Jan 30, 2025
SELL
$27.22 - $34.28 $45,266 - $57,007
-1,663 Reduced 2.5%
64,888 $1.81 Million
Q3 2024

Nov 12, 2024
SELL
$30.46 - $46.86 $36,308 - $55,857
-1,192 Reduced 1.76%
66,551 $2.13 Million
Q2 2024

Aug 01, 2024
SELL
$38.46 - $50.95 $105,880 - $140,265
-2,753 Reduced 3.91%
67,743 $3.29 Million
Q1 2024

May 09, 2024
BUY
$37.48 - $44.74 $9,295 - $11,095
248 Added 0.35%
70,496 $2.9 Million
Q4 2023

Feb 08, 2024
SELL
$33.36 - $45.71 $18,281 - $25,049
-548 Reduced 0.77%
70,248 $3.14 Million
Q3 2023

Nov 09, 2023
SELL
$40.03 - $51.51 $636,396 - $818,905
-15,898 Reduced 18.34%
70,796 $2.95 Million
Q2 2023

Aug 08, 2023
BUY
$40.45 - $48.0 $256,372 - $304,224
6,338 Added 7.89%
86,694 $3.76 Million
Q1 2023

May 11, 2023
BUY
$34.96 - $43.94 $532,790 - $669,645
15,240 Added 23.4%
80,356 $3.53 Million
Q4 2022

Feb 14, 2023
BUY
$36.55 - $51.15 $24,232 - $33,912
663 Added 1.03%
65,116 $2.38 Million
Q3 2022

Nov 10, 2022
BUY
$47.75 - $66.88 $124,723 - $174,690
2,612 Added 4.22%
64,453 $3.13 Million
Q2 2022

Aug 11, 2022
BUY
$40.55 - $51.76 $87,101 - $111,180
2,148 Added 3.6%
61,841 $3.05 Million
Q1 2022

May 12, 2022
BUY
$36.56 - $50.98 $10,200 - $14,223
279 Added 0.47%
59,693 $3.04 Million
Q4 2021

Feb 10, 2022
BUY
$37.1 - $57.45 $32,165 - $49,809
867 Added 1.48%
59,414 $2.81 Million
Q3 2021

Nov 12, 2021
BUY
$38.45 - $55.66 $392,882 - $568,733
10,218 Added 21.14%
58,547 $2.31 Million
Q2 2021

Aug 05, 2021
SELL
$49.67 - $68.96 $46,888 - $65,098
-944 Reduced 1.92%
48,329 $2.65 Million
Q1 2021

May 06, 2021
SELL
$60.06 - $89.52 $86,426 - $128,819
-1,439 Reduced 2.84%
49,273 $3.12 Million
Q4 2020

Feb 10, 2021
SELL
$53.26 - $77.18 $393,165 - $569,742
-7,382 Reduced 12.71%
50,712 $3.65 Million
Q3 2020

Nov 12, 2020
BUY
$57.51 - $75.36 $1.3 Million - $1.71 Million
22,659 Added 63.95%
58,094 $4.38 Million
Q2 2020

Aug 13, 2020
BUY
$32.91 - $59.82 $656,817 - $1.19 Million
19,958 Added 128.95%
35,435 $2.12 Million
Q1 2020

May 06, 2020
BUY
$26.79 - $38.99 $375 - $545
14 Added 0.09%
15,477 $540,000
Q4 2019

Feb 05, 2020
BUY
$29.07 - $35.63 $930 - $1,140
32 Added 0.21%
15,463 $450,000
Q3 2019

Oct 23, 2019
SELL
$28.19 - $41.75 $2,396 - $3,548
-85 Reduced 0.55%
15,431 $535,000
Q2 2019

Aug 14, 2019
BUY
$19.91 - $28.97 $10,711 - $15,585
538 Added 3.59%
15,516 $443,000
Q1 2019

May 01, 2019
SELL
$18.84 - $21.36 $6,236 - $7,070
-331 Reduced 2.16%
14,978 $316,000
Q4 2018

Jan 31, 2019
BUY
$17.56 - $21.2 $87,800 - $106,000
5,000 Added 48.5%
15,309 $305,000
Q3 2018

Nov 07, 2018
SELL
$17.1 - $23.55 $12,397 - $17,073
-725 Reduced 6.57%
10,309 $208,000
Q2 2018

Aug 06, 2018
BUY
$14.65 - $23.75 $161,648 - $262,057
11,034 New
11,034 $246,000
Q4 2017

Feb 09, 2018
SELL
$15.3 - $17.4 $159,257 - $181,116
-10,409 Closed
0 $0
Q3 2017

Nov 06, 2017
BUY
$13.7 - $15.65 $142,603 - $162,900
10,409
10,409 $161,000

Others Institutions Holding SLP

# of Institutions
169
Shares Held
17M
Call Options Held
0
Put Options Held
35.8K
View Full List

About Simulations Plus, Inc.

SLP Quotes by TradingView
  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $335M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email